PMA supplement
P820063 S054: PARAPERM O2 (PASIFOCON A) RGP CONTACT LENS
FDA PMA supplement · Normal 180 Day Track · CooperVision, Inc.
Key facts
| Original PMA | P820063 |
|---|---|
| Supplement number | S054 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Location Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | PARAPERM O2 (PASIFOCON A) RGP CONTACT LENS |
| Generic name | Lens, contact (polymethylmethacrylate) |
| Applicant | CooperVision, Inc. |
| Product code | HPX |
| Received date | Nov 12, 1993 |
| Decision date | Jan 4, 1994 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: